13F filer · CIK 1055951
ORBIMED ADVISORS LLC
New York, NY · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$5.4B
+$351.4M vs prior
Positions
129
New / sold out
42 / 26
Added / reduced
32 / 27
Turnover
20.2%
buys $1.1B · sells $1.4B
Top-10 weight
42.1%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | UNITEDHEALTH GROUP INC | +161,100 | – | +$67.0M |
| New | ASCENDIS PHARMA A/S | +244,456 | – | +$65.2M |
| New | HUMANA INC | +164,100 | – | +$65.2M |
| New | ODYSSEY THERAPEUTICS INC | +3,001,198 | – | +$56.2M |
| New | ARCUTIS BIOTHERAPEUTICS INC | +2,042,000 | – | +$53.5M |
| Added | COGENT BIOSCIENCES INC | +1,359,200 | +422.0% | +$52.6M |
| New | SPDR SERIES TRUSTPUT | +300,000 | – | +$47.5M |
| Added | ASTRAZENECA PLC | +245,500 | +36.6% | +$45.9M |
| Added | STRUCTURE THERAPEUTICS INC | +733,997 | +49.7% | +$39.4M |
| New | ABIVAX SACALL | +200,000 | – | +$26.7M |
64 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | MDXHEALTH SACALL | -124,306,000 | -100.0% | $-285.9M |
| Sold out | AVITA MEDICAL INCCALL | -40,966,100 | -100.0% | $-154.4M |
| Sold out | MYRIAD GENETICS INC | -125,000,000 | -100.0% | $-122.9M |
| Reduced | ENLIVEN THERAPEUTICS INC | -1,182,906 | -14.9% | $-60.0M |
| Sold out | PFIZER INC | -1,946,500 | -100.0% | $-54.7M |
| Reduced | DISC MEDICINE INC | -710,015 | -66.5% | $-51.9M |
| Sold out | DANAHER CORP DEL | -265,800 | -100.0% | $-50.4M |
| Reduced | SIONNA THERAPEUTICS INC | -974,825 | -27.6% | $-42.9M |
| Sold out | ASCENDIS PHARMA A/S | -181,977 | -100.0% | $-41.6M |
| Reduced | ARGENX SE | -44,020 | -32.2% | $-40.8M |
43 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | EDGEWISE THERAPEUTICS INCCOM | 15,518,492 | $630.5M | 11.68% |
| 2 | ENLIVEN THERAPEUTICS INCCOM | 6,776,632 | $343.9M | 6.37% |
| 3 | LLYELI LILLY & CO | 257,900 | $309.3M | 5.73% |
| 4 | MBX BIOSCIENCES INCCOM | 3,428,736 | $189.3M | 3.51% |
| 5 | SINOVAC BIOTECH LTDSHS | 2,718,735 | $184.5M | 3.42% |
| 6 | ASTRAZENECA PLCORD | 915,700 | $171.1M | 3.17% |
| 7 | STRUCTURE THERAPEUTICS INCSPONSORED ADS | 2,209,400 | $118.6M | 2.20% |
| 8 | SIONNA THERAPEUTICS INCCOM | 2,555,877 | $112.4M | 2.08% |
| 9 | CORVUS PHARMACEUTICALS INCCOM | 7,165,006 | $107.0M | 1.98% |
| 10 | ARRIVENT BIOPHARMA INCCOM | 3,027,328 | $105.2M | 1.95% |
119 more rows. Subscribe for $29/month to see every row, download the data and use the API.